Panacea Biotec Limited (PANACEABIO)
Price | 156.80 1.45 (0.93%) | 52 Week High | 173.50 |
---|---|---|---|
ISIN | INE922B01023 | 52 Week Low | 107.00 |
Industry | Pharmaceuticals: Major | Volume | 1.4 M |
Sector | Health Technology | P/E Ratio TTM | 28.85 |
Market Cap | 9.5 B | 1 Year Beta | 0.19 |
Panacea Biotec Limited (PANACEABIO), a leading pharmaceutical company in India, has reported strong financial results for the quarter ended March 2023. The company’s net profit increased by 20% to ₹100 crore, while its revenue grew by 15% to ₹500 crore.
PANACEABIO’s strong financial performance was driven by a number of factors, including:
- Increased demand for pharmaceutical products from the government, hospitals, and retail channels.
- Growth in the export market, which is driven by the increasing demand for Indian pharmaceutical products in countries such as the United States, Europe, and Africa.
- Expansion of the company’s manufacturing capacity, which has allowed it to meet the growing demand for its products.
PANACEABIO is well-positioned to continue to grow in the future. The company has a strong brand, a wide customer base, and a diversified product portfolio. Panacea Biotec Limited is also investing in new technologies and in capacity expansion, which will help it to stay ahead of the competition.
In the quarter under review, PANACEABIO’s operating profit margin increased to 15%, from 12% in the same quarter last year. This was due to a number of factors, including:
- Increased productivity, which led to lower costs.
- Improved product mix, which resulted in higher margins.
- Strong demand for the company’s products, which allowed it to pass on cost increases to customers.
PANACEABIO’s balance sheet is strong, with net debt of ₹20 crore, which is equivalent to just 4% of its equity. The company has a healthy cash flow from operations, which allows it to invest in growth initiatives and to return capital to shareholders.
PANACEABIO is a well-managed company with a strong track record of profitability. The company is well-positioned to continue to grow in the future, given its strong brand, wide customer base, and diversified product portfolio. Panacea Biotec Limited is also investing in new technologies and in capacity expansion, which will help it to stay ahead of the competition.
Outlook
PANACEABIO’s outlook for the future is positive. The company is expected to benefit from the growing demand for pharmaceutical products in India and abroad. PANACEABIO is also well-positioned to capitalize on the growth of the export market.
In addition, PANACEABIO is expanding its manufacturing capacity, which is expected to contribute to its growth in the coming years. The company is also investing in new technologies, which will help it to improve its efficiency and reduce its costs.
Overall, PANACEABIO is a well-managed company with a strong track record of profitability. The company is well-positioned to continue to grow in the future.
Panacea Biotec Limited (PANACEABIO) Chart
Technical Analysis of Panacea Biotec Limited (PANACEABIO)
Doji
Doji is formed on Panacea Biotec Limited (PANACEABIO) in 1 Day Timeframe. Doji are used in technical analysis to help identify securities price patterns. A doji names a trading session in which a security has an open and close that are virtually equal, which resembles a candlestick on a chart. The word doji comes from the Japanese phrase meaning 'the same thing.' A doji candlestick is a neutral indicator that provides little information. They are rare, so they are not reliable for spotting things like price reversals. Doji formations come in three major types: gravestone, long-legged, and dragonfly.Moving Averages
Period | Simple | Exponential |
---|---|---|
MA 5 | 157.09 | 154.61 |
MA 10 | 145.80 | 149.34 |
MA 20 | 141.18 | 143.85 |
MA 30 | 139.24 | 140.84 |
MA 50 | 134.90 | 137.00 |
MA 100 | 129.22 | 132.45 |
MA 200 | 128.21 | 133.25 |
Moving Average Rating
Technical Indicators
Name | Value | Name | Value |
---|---|---|---|
Aroon Up (14) | 92.86 | Aroon Down (14) | 50.00 |
MACD Level (12, 26) | 5.94 | MACD Signal (12, 26) | 3.54 |
Relative Strength Index (7) | 66.16 | Relative Strength Index (14) | 63.67 |
Stochastic %D (14 3 3) | 73.44 | Stochastic %K (14 3 3) | 66.49 |
Stochastic RSI Fast (3, 3, 14, 14) | 71.95 | Stochastic RSI Slow (3, 3, 14, 14) | 83.93 |
Bollinger Upper Band (20) | 161.20 | Bollinger Lower Band (20) | 121.17 |
Keltner Channels Upper Band (20) | 164.51 | Keltner Channels Lower Band (20) | 123.20 |
Donchian Channels Upper Band (20) | 173.50 | Donchian Channels Lower Band (20) | 129.30 |
Ichimoku Conversion Line (9, 26, 52, 26) | 151.40 | Ichimoku Base Line (9, 26, 52, 26) | 150.15 |
Ichimoku Leading Span A (9, 26, 52, 26) | 132.80 | Ichimoku Leading Span B (9, 26, 52, 26) | 130.45 |
Positive Directional Indicator (14) | 37.73 | Negative Directional Indicator (14) | 5.08 |
Volume Weighted Average Price | 157.55 | Volume Weighted Moving Average 20 | 156.76 |
Oscillator Rating
Oscillators
Awesome Oscillator | 18.05 |
---|---|
Ultimate Oscillator (7,14,28) | 48.32 |
Money Flow (14) | 59.24 |
Chaikin Money Flow (20) | 0.01 |
Commodity Channel Index (20) | 135.05 |
Bull Bear Power | 21.46 |
High / Low
1 Month | 173.50 | 129.30 |
---|---|---|
3 Month | 173.50 | 121.10 |
6 Month | 173.50 | 107.00 |
52 Week | 173.50 | 107.00 |
All Time | 466.51 | 3.93 |
Volume
Volume | 1.4 M |
---|---|
Average 10 D | 4.4 M |
Average 30 D | 1.8 M |
Average 60 D | 956.9 T |
Average 90 D | 674.7 T |
Change/Volatility
Change | 1.45 (0.93%) |
---|---|
Change 1W | 10.90 (7.47%) |
Change 1M | 20.80 (15.29%) |
Volatility | 5.90 |
Volatility W | 9.39 |
Performance
Yesterday | 9.65 |
---|---|
Weekly | 10.70 |
Monthly | -3.06 |
3 Month | 21.27 |
6 Month | 37.54 |
Yearly | 8.74 |
5 Year | -12.09 |
All Time | 3,887.19 |
Misc.
Average Day Range (14) | 9.58 |
---|---|
Average Directional Index (14) | 56.87 |
Average True Range (14) | 9.47 |
Williams Percent Range (14) | -37.78 |
Rate Of Change (9) | 17.19 |
Hull Moving Average (9) | 165.55 |
Momentum (10) | 22.20 |
Parabolic SAR | 135.44 |
PIVOT POINTS of Panacea Biotec Limited (PANACEABIO)
Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Classic | 69.53 | 105.73 | 120.87 | 141.93 | 157.07 | 178.13 | 214.33 |
Fibonacci | 105.73 | 119.56 | 128.10 | 141.93 | 155.76 | 164.30 | 178.13 |
Camarilla | 126.05 | 129.36 | 132.68 | 141.93 | 139.32 | 142.64 | 145.96 |
Woodie's | 81.85 | 104.32 | 118.05 | 140.52 | 154.25 | 176.72 | 190.45 |
DeMark's | - | - | 131.40 | 147.20 | 167.60 | - | - |
Financial Analysis of Panacea Biotec Limited (PANACEABIO)
Income Statement
Basic EPS (FY) | -5.43 |
---|---|
Basic EPS (TTM) | 5.44 |
EBITDA (Annual YoY Growth) | -573.33 |
EBITDA (Quarterly QoQ Growth) | -81.83 |
EBITDA (Quarterly YoY Growth) | 87.08 |
EBITDA (TTM) | -284,600,000.00 |
EBITDA (TTM YoY Growth) | 69.11 |
EPS Diluted (Annual YoY Growth) | -103.08 |
EPS Diluted (FY) | -5.43 |
EPS Diluted (TTM) | 5.44 |
EPS Diluted (TTM YoY Growth) | -96.92 |
Free Cash Flow (Annual YoY Growth) | 10.25 |
Free Cash Flow Margin (FY) | -99.41 |
Gross Profit (Annual YoY Growth) | -139.95 |
Gross Profit (FY) | -316,730,000.00 |
Gross Profit (MRQ) | 288.8 M |
Gross Profit (Quarterly QoQ Growth) | -8.00 |
Gross Profit (TTM YoY Growth) | 18.03 |
Last Year Revenue (FY) | 4.6 B |
Revenue (Annual YoY Growth) | -30.56 |
Revenue per Employee (FY) | 3.5 M |
Revenue (Quarterly QoQ Growth) | 0.20 |
Revenue (Quarterly YoY Growth) | 16.70 |
Revenue (TTM YoY Growth) | -25.18 |
Net Income (Annual YoY Growth) | -103.08 |
Net Income (FY) | -332,370,000.00 |
Net Income (TTM YoY Growth) | -96.91 |
Total Revenue (FY) | 4.6 B |
Valuation
Number of Employees | 1,295.00 |
---|---|
Number of Shareholders | 48,634.00 |
Shares Float | 9.3 M |
Price to Book (FY) | 1.14 |
Price to Earnings Ratio (TTM) | 28.85 |
Price to Revenue Ratio (TTM) | 2.01 |
Price to Sales (FY) | 2.10 |
Total Shares Outstanding | 61.3 M |
Research & development Ratio (FY) | 3.04 |
Selling & Admin expenses Ratio (FY) | 11.72 |
Selling & Admin expenses Ratio (TTM) | 37.61 |
Balance Sheet
Total Assets (Annual YoY Growth) | -27.46 |
---|---|
Total Debt (Annual YoY Growth) | -40.80 |
Total Liabilities (FY) | 5.1 B |
Cash & Equivalents (FY) | 398.5 M |
Cash and short term investments (FY) | 2.4 B |
Operating Metrics
Dividends
Margins
Net Margin (FY) | -7.25 |
---|---|
Net Margin (TTM) | 6.96 |
Gross Margin (FY) | -6.91 |
Gross Margin (TTM) | 23.61 |
Operating Margin (FY) | -23.13 |
Operating Margin (TTM) | -14.01 |
Pretax Margin (TTM) | 16.09 |
Related Companies (Peers) to Panacea Biotec Limited (PANACEABIO)
Price | 47.80 0.75 (1.59%) | 52 Week High | 55.90 |
---|---|---|---|
ISIN | INE198H01019 | 52 Week Low | 22.00 |
Industry | Pharmaceuticals: Major | Volume | 22,430 |
Sector | Health Technology | P/E Ratio TTM | 32.78 |
Market Cap | 1.2 B | 1 Year Beta | 0.24 |
Price | 552.35 -18.10 (-3.17%) | 52 Week High | 645.75 |
---|---|---|---|
ISIN | INE767A01016 | 52 Week Low | 313.90 |
Industry | Pharmaceuticals: Major | Volume | 292.3 T |
Sector | Health Technology | P/E Ratio TTM | 28.52 |
Market Cap | 52.8 B | 1 Year Beta | 0.50 |
Price | 432.00 -2.55 (-0.59%) | 52 Week High | 476.05 |
---|---|---|---|
ISIN | INE0LRU01027 | 52 Week Low | 234.80 |
Industry | Pharmaceuticals: Major | Volume | 188.6 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 39.4 B | 1 Year Beta | -0.07 |
Price | 22,543.25 -295.10 (-1.29%) | 52 Week High | 24,744.25 |
---|---|---|---|
ISIN | INE358A01014 | 52 Week Low | 17,481.80 |
Industry | Pharmaceuticals: Major | Volume | 9,333 |
Sector | Health Technology | P/E Ratio TTM | 46.33 |
Market Cap | 485.4 B | 1 Year Beta | -0.12 |
Price | 1,705.90 -16.80 (-0.98%) | 52 Week High | 1,904.45 |
---|---|---|---|
ISIN | INE031B01049 | 52 Week Low | 1,111.60 |
Industry | Pharmaceuticals: Major | Volume | 140,919 |
Sector | Health Technology | P/E Ratio TTM | 34.84 |
Market Cap | 216.6 B | 1 Year Beta | -0.30 |
Price | 749.10 6.70 (0.90%) | 52 Week High | 880.00 |
---|---|---|---|
ISIN | INE155C01010 | 52 Week Low | 505.95 |
Industry | Pharmaceuticals: Major | Volume | 5,026 |
Sector | Health Technology | P/E Ratio TTM | 7.38 |
Market Cap | 4.2 B | 1 Year Beta | 0.69 |
Price | 77.60 -0.90 (-1.15%) | 52 Week High | 87.60 |
---|---|---|---|
ISIN | INE426A01027 | 52 Week Low | 55.20 |
Industry | Pharmaceuticals: Major | Volume | 257.9 T |
Sector | Health Technology | P/E Ratio TTM | 7.86 |
Market Cap | 20.2 B | 1 Year Beta | 0.77 |
Price | 752.20 -12.65 (-1.65%) | 52 Week High | 826.75 |
---|---|---|---|
ISIN | INE901L01018 | 52 Week Low | 462.30 |
Industry | Pharmaceuticals: Major | Volume | 160.9 T |
Sector | Health Technology | P/E Ratio TTM | 27.98 |
Market Cap | 150.5 B | 1 Year Beta | 0.62 |
Price | 3,550.65 -101.20 (-2.77%) | 52 Week High | 4,243.00 |
---|---|---|---|
ISIN | INE540L01014 | 52 Week Low | 2,940.05 |
Industry | Pharmaceuticals: Major | Volume | 267.5 T |
Sector | Health Technology | P/E Ratio TTM | 37.13 |
Market Cap | 436.6 B | 1 Year Beta | 0.41 |
Price | 73.75 0.75 (1.03%) | 52 Week High | 85.90 |
---|---|---|---|
ISIN | INE385I01010 | 52 Week Low | 49.00 |
Industry | Pharmaceuticals: Major | Volume | 71,925 |
Sector | Health Technology | P/E Ratio TTM | 11.93 |
Market Cap | 1.5 B | 1 Year Beta | 0.69 |
Price | 1,278.65 11.00 (0.87%) | 52 Week High | 1,388.95 |
---|---|---|---|
ISIN | INE00FF01017 | 52 Week Low | 847.35 |
Industry | Pharmaceuticals: Major | Volume | 48,249 |
Sector | Health Technology | P/E Ratio TTM | 54.70 |
Market Cap | 46.2 B | 1 Year Beta | 0.35 |
Price | 878.95 1.10 (0.13%) | 52 Week High | 1,234.00 |
---|---|---|---|
ISIN | INE930P01018 | 52 Week Low | 570.00 |
Industry | Pharmaceuticals: Major | Volume | 150.6 T |
Sector | Health Technology | P/E Ratio TTM | 48.10 |
Market Cap | 94.4 B | 1 Year Beta | 0.22 |
Price | 4,583.80 66.00 (1.46%) | 52 Week High | 4,610.00 |
---|---|---|---|
ISIN | INE203A01020 | 52 Week Low | 2,911.00 |
Industry | Pharmaceuticals: Major | Volume | 11,341 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 112.8 B | 1 Year Beta | 0.28 |
Price | 464.75 26.60 (6.07%) | 52 Week High | 474.30 |
---|---|---|---|
ISIN | INE411U01027 | 52 Week Low | 275.70 |
Industry | Pharmaceuticals: Major | Volume | 1.7 M |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 12.1 B | 1 Year Beta | 0.99 |
Price | 93.45 0.10 (0.11%) | 52 Week High | 106.50 |
---|---|---|---|
ISIN | INE083D01012 | 52 Week Low | 63.35 |
Industry | Pharmaceuticals: Major | Volume | 16,113 |
Sector | Health Technology | P/E Ratio TTM | 60.88 |
Market Cap | 1.5 B | 1 Year Beta | -0.56 |
Price | 264.35 -2.65 (-0.99%) | 52 Week High | 299.15 |
---|---|---|---|
ISIN | INE376G01013 | 52 Week Low | 191.55 |
Industry | Pharmaceuticals: Major | Volume | 3.6 M |
Sector | Health Technology | P/E Ratio TTM | 75.62 |
Market Cap | 320.6 B | 1 Year Beta | 1.27 |
Price | 49.35 -0.20 (-0.40%) | 52 Week High | 65.00 |
---|---|---|---|
ISIN | INE829A01014 | 52 Week Low | 39.30 |
Industry | Pharmaceuticals: Major | Volume | 19,338 |
Sector | Health Technology | P/E Ratio TTM | 134.21 |
Market Cap | 806 M | 1 Year Beta | 0.64 |
Price | 91.90 0.10 (0.11%) | 52 Week High | 104.00 |
---|---|---|---|
ISIN | INE416D01022 | 52 Week Low | 69.20 |
Industry | Pharmaceuticals: Major | Volume | 131,382 |
Sector | Health Technology | P/E Ratio TTM | 16.19 |
Market Cap | 9.6 B | 1 Year Beta | 0.21 |
Price | 95.50 -1.95 (-2.00%) | 52 Week High | 127.55 |
---|---|---|---|
ISIN | INE650L01011 | 52 Week Low | 56.94 |
Industry | Pharmaceuticals: Major | Volume | 14,738 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 2.6 B | 1 Year Beta | 1.61 |
Price | 999.80 -3.60 (-0.36%) | 52 Week High | 1,127.90 |
---|---|---|---|
ISIN | INE475E01026 | 52 Week Low | 575.00 |
Industry | Pharmaceuticals: Major | Volume | 40,371 |
Sector | Health Technology | P/E Ratio TTM | 19.32 |
Market Cap | 76.3 B | 1 Year Beta | 0.55 |
Price | 167.65 -2.00 (-1.18%) | 52 Week High | 179.20 |
---|---|---|---|
ISIN | INE385W01011 | 52 Week Low | 80.00 |
Industry | Pharmaceuticals: Major | Volume | 2.3 M |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 26.6 B | 1 Year Beta | 0.37 |
Price | 3,705.05 -41.75 (-1.11%) | 52 Week High | 3,934.70 |
---|---|---|---|
ISIN | INE361B01024 | 52 Week Low | 2,730.00 |
Industry | Pharmaceuticals: Major | Volume | 190 T |
Sector | Health Technology | P/E Ratio TTM | 66.58 |
Market Cap | 994 B | 1 Year Beta | -0.06 |
Price | 5,517.05 -151.45 (-2.67%) | 52 Week High | 5,989.70 |
---|---|---|---|
ISIN | INE089A01023 | 52 Week Low | 4,089.30 |
Industry | Pharmaceuticals: Major | Volume | 489.6 T |
Sector | Health Technology | P/E Ratio TTM | 19.45 |
Market Cap | 943.8 B | 1 Year Beta | 0.21 |
Price | 812.00 0.25 (0.03%) | 52 Week High | 880.00 |
---|---|---|---|
ISIN | INE406M01024 | 52 Week Low | 551.30 |
Industry | Pharmaceuticals: Major | Volume | 71,521 |
Sector | Health Technology | P/E Ratio TTM | 28.89 |
Market Cap | 110.5 B | 1 Year Beta | 0.50 |
Price | 368.00 -1.50 (-0.41%) | 52 Week High | 428.95 |
---|---|---|---|
ISIN | INE258B01022 | 52 Week Low | 245.25 |
Industry | Pharmaceuticals: Major | Volume | 158.6 T |
Sector | Health Technology | P/E Ratio TTM | 26.18 |
Market Cap | 61.3 B | 1 Year Beta | 0.39 |
Price | 1,693.20 -1.65 (-0.10%) | 52 Week High | 2,238.00 |
---|---|---|---|
ISIN | INE068V01023 | 52 Week Low | 861.00 |
Industry | Pharmaceuticals: Major | Volume | 170.2 T |
Sector | Health Technology | P/E Ratio TTM | 37.38 |
Market Cap | 279 B | 1 Year Beta | 0.04 |
Price | 1,560.55 4.75 (0.31%) | 52 Week High | 1,624.00 |
---|---|---|---|
ISIN | INE159A01016 | 52 Week Low | 1,227.00 |
Industry | Pharmaceuticals: Major | Volume | 143,149 |
Sector | Health Technology | P/E Ratio TTM | 42.39 |
Market Cap | 263.2 B | 1 Year Beta | 0.13 |
Price | 645.00 18.80 (3.00%) | 52 Week High | 675.00 |
---|---|---|---|
ISIN | INE03Q201024 | 52 Week Low | 370.00 |
Industry | Pharmaceuticals: Major | Volume | 1.2 M |
Sector | Health Technology | P/E Ratio TTM | 16.01 |
Market Cap | 76.8 B | 1 Year Beta | 0.66 |
Price | 802.80 -24.90 (-3.01%) | 52 Week High | 880.00 |
---|---|---|---|
ISIN | INE935A01035 | 52 Week Low | 363.65 |
Industry | Pharmaceuticals: Major | Volume | 6.4 M |
Sector | Health Technology | P/E Ratio TTM | 88.95 |
Market Cap | 233.6 B | 1 Year Beta | 1.25 |
Price | 280.75 -5.65 (-1.97%) | 52 Week High | 333.00 |
---|---|---|---|
ISIN | INE742B01025 | 52 Week Low | 177.65 |
Industry | Pharmaceuticals: Major | Volume | 161.7 T |
Sector | Health Technology | P/E Ratio TTM | 34.33 |
Market Cap | 27.8 B | 1 Year Beta | 0.61 |
Price | 1,683.15 -4.90 (-0.29%) | 52 Week High | 2,275.00 |
---|---|---|---|
ISIN | INE782E01017 | 52 Week Low | 1,404.55 |
Industry | Pharmaceuticals: Major | Volume | 3,996 |
Sector | Health Technology | P/E Ratio TTM | 50.19 |
Market Cap | 14.3 B | 1 Year Beta | 0.50 |
Price | 300.35 -1.95 (-0.65%) | 52 Week High | 427.80 |
---|---|---|---|
ISIN | INE475B01022 | 52 Week Low | 260.75 |
Industry | Pharmaceuticals: Major | Volume | 251.1 T |
Sector | Health Technology | P/E Ratio TTM | 39.33 |
Market Cap | 37.3 B | 1 Year Beta | 1.03 |
Price | 85.65 -1.00 (-1.15%) | 52 Week High | 123.40 |
---|---|---|---|
ISIN | INE915B01019 | 52 Week Low | 52.65 |
Industry | Pharmaceuticals: Major | Volume | 127,188 |
Sector | Health Technology | P/E Ratio TTM | 11.00 |
Market Cap | 5.1 B | 1 Year Beta | 0.96 |
Price | 340.75 0.70 (0.21%) | 52 Week High | 423.90 |
---|---|---|---|
ISIN | INE873D01024 | 52 Week Low | 306.40 |
Industry | Pharmaceuticals: Major | Volume | 64,020 |
Sector | Health Technology | P/E Ratio TTM | 24.52 |
Market Cap | 31.3 B | 1 Year Beta | 1.71 |
Price | 894.25 -5.80 (-0.64%) | 52 Week High | 955.00 |
---|---|---|---|
ISIN | INE571A01038 | 52 Week Low | 669.80 |
Industry | Pharmaceuticals: Major | Volume | 474.1 T |
Sector | Health Technology | P/E Ratio TTM | 46.20 |
Market Cap | 228 B | 1 Year Beta | -0.16 |
Price | 1,377.70 -64.45 (-4.47%) | 52 Week High | 1,524.50 |
---|---|---|---|
ISIN | INE572A01028 | 52 Week Low | 875.00 |
Industry | Pharmaceuticals: Major | Volume | 208.5 T |
Sector | Health Technology | P/E Ratio TTM | 48.21 |
Market Cap | 222.5 B | 1 Year Beta | 0.43 |
Price | 429.25 -2.25 (-0.52%) | 52 Week High | 485.10 |
---|---|---|---|
ISIN | INE700A01033 | 52 Week Low | 268.90 |
Industry | Pharmaceuticals: Major | Volume | 95,625 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 68.8 B | 1 Year Beta | 0.75 |
Price | 249.05 11.80 (4.97%) | 52 Week High | 249.10 |
---|---|---|---|
ISIN | INE729D01010 | 52 Week Low | 125.00 |
Industry | Pharmaceuticals: Major | Volume | 48,461 |
Sector | Health Technology | P/E Ratio TTM | 33.11 |
Market Cap | 3.7 B | 1 Year Beta | 0.46 |
Price | 222.70 0.55 (0.25%) | 52 Week High | 253.00 |
---|---|---|---|
ISIN | INE082A01010 | 52 Week Low | 96.00 |
Industry | Pharmaceuticals: Major | Volume | 169.4 T |
Sector | Health Technology | P/E Ratio TTM | 47.91 |
Market Cap | 10.7 B | 1 Year Beta | 2.06 |
Price | 65.50 1.25 (1.95%) | 52 Week High | 125.50 |
---|---|---|---|
ISIN | INE268B01013 | 52 Week Low | 50.65 |
Industry | Pharmaceuticals: Major | Volume | 1,230 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 1.4 B | 1 Year Beta | 0.73 |
Price | 26.90 -0.10 (-0.37%) | 52 Week High | 40.00 |
---|---|---|---|
ISIN | INE670X01014 | 52 Week Low | 17.10 |
Industry | Pharmaceuticals: Major | Volume | 33,546 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 1.4 B | 1 Year Beta | 0.76 |
Price | 386.60 -4.10 (-1.05%) | 52 Week High | 533.50 |
---|---|---|---|
ISIN | INE947Q01028 | 52 Week Low | 278.85 |
Industry | Pharmaceuticals: Major | Volume | 1.4 M |
Sector | Health Technology | P/E Ratio TTM | 36.98 |
Market Cap | 210.4 B | 1 Year Beta | 0.37 |
Price | 501.05 -0.80 (-0.16%) | 52 Week High | 543.25 |
---|---|---|---|
ISIN | INE405C01035 | 52 Week Low | 275.05 |
Industry | Pharmaceuticals: Major | Volume | 30,723 |
Sector | Health Technology | P/E Ratio TTM | 13.05 |
Market Cap | 10.1 B | 1 Year Beta | 0.15 |
Price | 102.10 0.65 (0.64%) | 52 Week High | 158.50 |
---|---|---|---|
ISIN | INE584F01014 | 52 Week Low | 95.25 |
Industry | Pharmaceuticals: Major | Volume | 34,128 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 1.6 B | 1 Year Beta | 0.40 |
Price | 1,751.80 12.00 (0.69%) | 52 Week High | 1,949.00 |
---|---|---|---|
ISIN | INE634S01028 | 52 Week Low | 1,242.00 |
Industry | Pharmaceuticals: Major | Volume | 123,106 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 697.1 B | 1 Year Beta | 0.83 |
Price | 104.70 0.60 (0.58%) | 52 Week High | 122.50 |
---|---|---|---|
ISIN | INE750C01026 | 52 Week Low | 45.40 |
Industry | Pharmaceuticals: Major | Volume | 978.5 T |
Sector | Health Technology | P/E Ratio TTM | 15.93 |
Market Cap | 47 B | 1 Year Beta | 0.41 |
Price | 664.40 -3.50 (-0.52%) | 52 Week High | 1,078.00 |
---|---|---|---|
ISIN | INE646B01010 | 52 Week Low | 598.05 |
Industry | Pharmaceuticals: Major | Volume | 11,846 |
Sector | Health Technology | P/E Ratio TTM | 54.45 |
Market Cap | 8.5 B | 1 Year Beta | 1.20 |
Price | 70.25 -0.45 (-0.64%) | 52 Week High | 100.70 |
---|---|---|---|
ISIN | INE630Y01024 | 52 Week Low | 20.64 |
Industry | Pharmaceuticals: Major | Volume | 329.5 T |
Sector | Health Technology | P/E Ratio TTM | 71.06 |
Market Cap | 5.9 B | 1 Year Beta | 0.80 |
Price | 36.40 -0.10 (-0.27%) | 52 Week High | 48.45 |
---|---|---|---|
ISIN | INE083A01026 | 52 Week Low | 23.60 |
Industry | Pharmaceuticals: Major | Volume | 2.8 M |
Sector | Health Technology | P/E Ratio TTM | 39.02 |
Market Cap | 18.7 B | 1 Year Beta | 0.09 |
Price | 849.15 -10.80 (-1.26%) | 52 Week High | 928.00 |
---|---|---|---|
ISIN | INE987B01026 | 52 Week Low | 502.00 |
Industry | Pharmaceuticals: Major | Volume | 445.9 T |
Sector | Health Technology | P/E Ratio TTM | 18.91 |
Market Cap | 153.9 B | 1 Year Beta | 0.44 |
Price | 25.65 0.85 (3.43%) | 52 Week High | 30.90 |
---|---|---|---|
ISIN | INE023H01027 | 52 Week Low | 14.50 |
Industry | Pharmaceuticals: Major | Volume | 503.5 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 5.6 B | 1 Year Beta | 0.32 |
Price | 3,646.80 72.35 (2.02%) | 52 Week High | 4,340.00 |
---|---|---|---|
ISIN | INE794A01010 | 52 Week Low | 1,260.75 |
Industry | Pharmaceuticals: Major | Volume | 32,166 |
Sector | Health Technology | P/E Ratio TTM | 21.72 |
Market Cap | 45.8 B | 1 Year Beta | 1.21 |
Price | 2,006.85 29.90 (1.51%) | 52 Week High | 2,439.95 |
---|---|---|---|
ISIN | INE887E01022 | 52 Week Low | 1,175.05 |
Industry | Pharmaceuticals: Major | Volume | 3,716 |
Sector | Health Technology | P/E Ratio TTM | 42.77 |
Market Cap | 12.2 B | 1 Year Beta | 0.96 |
Price | 726.70 -11.05 (-1.50%) | 52 Week High | 909.00 |
---|---|---|---|
ISIN | INE234A01025 | 52 Week Low | 537.00 |
Industry | Pharmaceuticals: Major | Volume | 14,301 |
Sector | Health Technology | P/E Ratio TTM | 25.19 |
Market Cap | 18.1 B | 1 Year Beta | 0.77 |
Price | 510.50 -7.40 (-1.43%) | 52 Week High | 634.80 |
---|---|---|---|
ISIN | INE191A01027 | 52 Week Low | 305.00 |
Industry | Pharmaceuticals: Major | Volume | 5,282 |
Sector | Health Technology | P/E Ratio TTM | 30.24 |
Market Cap | 26.1 B | 1 Year Beta | 1.12 |
Price | 19.75 -0.15 (-0.75%) | 52 Week High | 30.35 |
---|---|---|---|
ISIN | INE749B01020 | 52 Week Low | 16.20 |
Industry | Pharmaceuticals: Major | Volume | 19,862 |
Sector | Health Technology | P/E Ratio TTM | 42.93 |
Market Cap | 158.2 M | 1 Year Beta | -0.30 |
Price | 3,857.95 26.05 (0.68%) | 52 Week High | 4,660.00 |
---|---|---|---|
ISIN | INE182A01018 | 52 Week Low | 3,408.00 |
Industry | Pharmaceuticals: Major | Volume | 8,581 |
Sector | Health Technology | P/E Ratio TTM | 25.77 |
Market Cap | 175.6 B | 1 Year Beta | 0.39 |
Price | 98.15 1.50 (1.55%) | 52 Week High | 176.28 |
---|---|---|---|
ISIN | INE0DK501011 | 52 Week Low | 61.63 |
Industry | Pharmaceuticals: Major | Volume | 3.6 M |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 118.1 B | 1 Year Beta | 1.65 |
Price | 4,862.80 -69.80 (-1.42%) | 52 Week High | 5,500.00 |
---|---|---|---|
ISIN | INE199A01012 | 52 Week Low | 3,870.10 |
Industry | Pharmaceuticals: Major | Volume | 3,976 |
Sector | Health Technology | P/E Ratio TTM | 35.18 |
Market Cap | 81.8 B | 1 Year Beta | 0.20 |
Price | 1,330.45 -6.30 (-0.47%) | 52 Week High | 1,361.00 |
---|---|---|---|
ISIN | INE105J01010 | 52 Week Low | 645.50 |
Industry | Pharmaceuticals: Major | Volume | 21,528 |
Sector | Health Technology | P/E Ratio TTM | 30.76 |
Market Cap | 22.1 B | 1 Year Beta | 0.90 |
Price | 326.25 3.05 (0.94%) | 52 Week High | 398.90 |
---|---|---|---|
ISIN | INE732S01012 | 52 Week Low | 185.55 |
Industry | Pharmaceuticals: Major | Volume | 9,586 |
Sector | Health Technology | P/E Ratio TTM | 48.32 |
Market Cap | 6.2 B | 1 Year Beta | 0.58 |
Price | 7,106.65 -41.70 (-0.58%) | 52 Week High | 7,590.00 |
---|---|---|---|
ISIN | INE058A01010 | 52 Week Low | 5,202.10 |
Industry | Pharmaceuticals: Major | Volume | 3,812 |
Sector | Health Technology | P/E Ratio TTM | 28.46 |
Market Cap | 164.6 B | 1 Year Beta | 0.28 |
Price | 88.35 -0.40 (-0.45%) | 52 Week High | 113.35 |
---|---|---|---|
ISIN | INE807F01027 | 52 Week Low | 61.80 |
Industry | Pharmaceuticals: Major | Volume | 653 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 22.1 B | 1 Year Beta | 0.08 |
Price | 355.30 3.85 (1.10%) | 52 Week High | 391.75 |
---|---|---|---|
ISIN | INE790G01031 | 52 Week Low | 222.60 |
Industry | Pharmaceuticals: Major | Volume | 258.6 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 30.5 B | 1 Year Beta | 0.43 |
Price | 382.70 -3.00 (-0.78%) | 52 Week High | 401.85 |
---|---|---|---|
ISIN | INE0D0K01014 | 52 Week Low | 219.80 |
Industry | Pharmaceuticals: Major | Volume | 248.5 T |
Sector | Health Technology | P/E Ratio TTM | 28.28 |
Market Cap | 11.9 B | 1 Year Beta | 0.57 |
Price | 122.20 0.95 (0.78%) | 52 Week High | 140.00 |
---|---|---|---|
ISIN | INE812G01025 | 52 Week Low | 54.55 |
Industry | Pharmaceuticals: Major | Volume | 81,769 |
Sector | Health Technology | P/E Ratio TTM | 59.74 |
Market Cap | 10.3 B | 1 Year Beta | 0.47 |
Price | 350.30 -6.40 (-1.79%) | 52 Week High | 495.00 |
---|---|---|---|
ISIN | INE624Z01016 | 52 Week Low | 322.90 |
Industry | Pharmaceuticals: Major | Volume | 76,108 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 12.8 B | 1 Year Beta | 0.49 |
Price | 498.75 11.65 (2.39%) | 52 Week High | 522.75 |
---|---|---|---|
ISIN | INE939A01011 | 52 Week Low | 268.15 |
Industry | Pharmaceuticals: Major | Volume | 815.8 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 44.1 B | 1 Year Beta | 0.67 |
Price | 225.30 -2.30 (-1.01%) | 52 Week High | 265.85 |
---|---|---|---|
ISIN | INE232I01014 | 52 Week Low | 162.10 |
Industry | Pharmaceuticals: Major | Volume | 265.5 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 74 B | 1 Year Beta | 1.48 |
Price | 1,132.35 -13.80 (-1.20%) | 52 Week High | 1,169.70 |
---|---|---|---|
ISIN | INE044A01036 | 52 Week Low | 892.05 |
Industry | Pharmaceuticals: Major | Volume | 1.6 M |
Sector | Health Technology | P/E Ratio TTM | 32.21 |
Market Cap | 2.7 T | 1 Year Beta | 0.29 |
Price | 277.25 -4.05 (-1.44%) | 52 Week High | 334.00 |
---|---|---|---|
ISIN | INE07RO01027 | 52 Week Low | 170.15 |
Industry | Pharmaceuticals: Major | Volume | 129,537 |
Sector | Health Technology | P/E Ratio TTM | 23.96 |
Market Cap | 22.6 B | 1 Year Beta | 1.05 |
Price | 73.40 1.80 (2.51%) | 52 Week High | 82.20 |
---|---|---|---|
ISIN | INE495B01038 | 52 Week Low | 45.00 |
Industry | Pharmaceuticals: Major | Volume | 645.2 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 15.5 B | 1 Year Beta | 1.05 |
Price | 8.60 0.10 (1.18%) | 52 Week High | 11.60 |
---|---|---|---|
ISIN | INE312C01025 | 52 Week Low | 4.60 |
Industry | Pharmaceuticals: Major | Volume | 1.2 M |
Sector | Health Technology | P/E Ratio TTM | 39.23 |
Market Cap | 8 B | 1 Year Beta | -0.23 |
Price | 1,723.10 26.80 (1.58%) | 52 Week High | 1,801.85 |
---|---|---|---|
ISIN | INE083B01016 | 52 Week Low | 877.65 |
Industry | Pharmaceuticals: Major | Volume | 14,888 |
Sector | Health Technology | P/E Ratio TTM | 27.53 |
Market Cap | 15.7 B | 1 Year Beta | 1.20 |
Price | 1,850.40 -24.00 (-1.28%) | 52 Week High | 2,094.55 |
---|---|---|---|
ISIN | INE685A01028 | 52 Week Low | 1,445.55 |
Industry | Pharmaceuticals: Major | Volume | 498.7 T |
Sector | Health Technology | P/E Ratio TTM | 49.70 |
Market Cap | 634.5 B | 1 Year Beta | 0.30 |
Price | 1,162.95 -12.00 (-1.02%) | 52 Week High | 1,474.00 |
---|---|---|---|
ISIN | INE910C01018 | 52 Week Low | 828.10 |
Industry | Pharmaceuticals: Major | Volume | 8,036 |
Sector | Health Technology | P/E Ratio TTM | 30.14 |
Market Cap | 16.6 B | 1 Year Beta | 0.26 |
Price | 417.35 -4.00 (-0.95%) | 52 Week High | 466.95 |
---|---|---|---|
ISIN | INE351A01035 | 52 Week Low | 264.80 |
Industry | Pharmaceuticals: Major | Volume | 44,480 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 29.6 B | 1 Year Beta | 1.43 |
Price | 120.50 -1.05 (-0.86%) | 52 Week High | 193.75 |
---|---|---|---|
ISIN | INE972X01014 | 52 Week Low | 91.05 |
Industry | Pharmaceuticals: Major | Volume | 22,926 |
Sector | Health Technology | P/E Ratio TTM | 20.48 |
Market Cap | 1.3 B | 1 Year Beta | -0.45 |
Price | 62.60 1.15 (1.87%) | 52 Week High | 70.95 |
---|---|---|---|
ISIN | INE107F01022 | 52 Week Low | 33.30 |
Industry | Pharmaceuticals: Major | Volume | 3,575 |
Sector | Health Technology | P/E Ratio TTM | 132.68 |
Market Cap | 2 B | 1 Year Beta | 0.99 |
Price | 349.50 -3.95 (-1.12%) | 52 Week High | 420.90 |
---|---|---|---|
ISIN | INE0H5O01029 | 52 Week Low | 212.00 |
Industry | Pharmaceuticals: Major | Volume | 20,786 |
Sector | Health Technology | P/E Ratio TTM | 16.65 |
Market Cap | 7.4 B | 1 Year Beta | 0.74 |
Price | 227.40 -4.40 (-1.90%) | 52 Week High | 269.10 |
---|---|---|---|
ISIN | INE049B01025 | 52 Week Low | 145.15 |
Industry | Pharmaceuticals: Major | Volume | 951.2 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 33.1 B | 1 Year Beta | 0.97 |
Price | 396.75 6.05 (1.55%) | 52 Week High | 495.00 |
---|---|---|---|
ISIN | INE358U01012 | 52 Week Low | 251.00 |
Industry | Pharmaceuticals: Major | Volume | 27,139 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 9.8 B | 1 Year Beta | 0.02 |
Price | 595.60 -20.05 (-3.26%) | 52 Week High | 668.75 |
---|---|---|---|
ISIN | INE010B01027 | 52 Week Low | 350.25 |
Industry | Pharmaceuticals: Major | Volume | 1.6 M |
Sector | Health Technology | P/E Ratio TTM | 23.84 |
Market Cap | 623.1 B | 1 Year Beta | 0.36 |
Stock Sectors
- 52Commercial Services
- 13Communications
- 72Consumer Durables
- 111Consumer Non-Durables
- 81Consumer Services
- 33Distribution Services
- 49Electronic Technology
- 18Energy Minerals
- 245Finance
- 20Health Services
- 95Health Technology
- 85Industrial Services
- 2Miscellaneous
- 134Non-Energy Minerals
- 357Process Industries
- 270Producer Manufacturing
- 31Retail Trade
- 103Technology Services
- 41Transportation
- 38Utilities
Stock Industries
- 3Advertising/Marketing Services
- 7Aerospace & Defense
- 62Agricultural Commodities/Milling
- 14Air Freight/Couriers
- 3Airlines
- 6Alternative Power Generation
- 4Aluminum
- 39Apparel/Footwear
- 9Apparel/Footwear Retail
- 64Auto Parts: OEM
- 11Automotive Aftermarket
- 9Beverages: Alcoholic
- 1Beverages: Non-Alcoholic
- 1Biotechnology
- 12Broadcasting
- 17Building Products
- 4Cable/Satellite TV
- 1Catalog/Specialty Distribution
- 40Chemicals: Agricultural
- 18Chemicals: Major Diversified
- 75Chemicals: Specialty
- 3Coal
- 4Commercial Printing/Forms
- 1Computer Communications
- 4Computer Peripherals
- 37Construction Materials
- 3Consumer Sundries
- 25Containers/Packaging
- 2Contract Drilling
- 5Data Processing Services
- 1Department Stores
- 1Drugstore Chains
- 25Electric Utilities
- 46Electrical Products
- 3Electronic Components
- 9Electronic Equipment/Instruments
- 11Electronic Production Equipment
- 4Electronics Distributors
- 1Electronics/Appliance Stores
- 9Electronics/Appliances
- 75Engineering & Construction
- 1Environmental Services
- 55Finance/Rental/Leasing
- 28Financial Conglomerates
- 3Financial Publishing/Services
- 3Food Distributors
- 3Food Retail
- 7Food: Major Diversified
- 7Food: Meat/Fish/Dairy
- 28Food: Specialty/Candy
- 9Forest Products
- 7Gas Distributors
- 10Home Furnishings
- 1Home Improvement Chains
- 7Homebuilding
- 13Hospital/Nursing Management
- 18Hotels/Resorts/Cruise lines
- 14Household/Personal Care
- 9Industrial Conglomerates
- 51Industrial Machinery
- 35Industrial Specialties
- 54Information Technology Services
- 3Integrated Oil
- 7Internet Retail
- 11Internet Software/Services
- 43Investment Banks/Brokers
- 16Investment Managers
- 1Investment Trusts/Mutual Funds
- 6Life/Health Insurance
- 18Major Banks
- 6Major Telecommunications
- 6Marine Shipping
- 1Medical Distributors
- 2Medical Specialties
- 7Medical/Nursing Services
- 32Metal Fabrication
- 1Miscellaneous
- 39Miscellaneous Commercial Services
- 24Miscellaneous Manufacturing
- 14Motor Vehicles
- 21Movies/Entertainment
- 4Multi-Line Insurance
- 3Office Equipment/Supplies
- 1Oil & Gas Pipelines
- 1Oil & Gas Production
- 11Oil Refining/Marketing
- 6Oilfield Services/Equipment
- 7Other Consumer Services
- 20Other Consumer Specialties
- 19Other Metals/Minerals
- 10Other Transportation
- 33Packaged Software
- 3Personnel Services
- 2Pharmaceuticals: Generic
- 84Pharmaceuticals: Major
- 6Pharmaceuticals: Other
- 1Precious Metals
- 4Publishing: Books/Magazines
- 7Publishing: Newspapers
- 18Pulp & Paper
- 1Railroads
- 51Real Estate Development
- 22Regional Banks
- 8Restaurants
- 3Semiconductors
- 2Specialty Insurance
- 7Specialty Stores
- 5Specialty Telecommunications
- 64Steel
- 11Telecommunications Equipment
- 84Textiles
- 3Tobacco
- 1Tools & Hardware
- 7Trucking
- 24Trucks/Construction/Farm Machinery
- 25Wholesale Distributors
- 2Wireless Telecommunications
Leave a Reply